Awakn Life Sciences Corp.
AWKNF
$0.065
-$0.0147-18.44%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 65.70% | 66.68% | 28.43% | 26.93% | 27.39% |
| Total Depreciation and Amortization | 11.38% | 44.23% | 85.71% | -88.35% | -93.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.14% | 123.21% | -260.48% | -306.08% | -250.18% |
| Change in Net Operating Assets | 79.31% | 45.23% | 679.14% | 83.57% | -23.17% |
| Cash from Operations | 85.26% | 84.59% | 10.26% | 23.03% | 13.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -198.90% | -198.90% | -- | -- | -- |
| Other Investing Activities | 175.76% | 169.98% | 165.60% | -259.52% | -1,112.24% |
| Cash from Investing | 100.00% | 100.00% | 162.86% | 80.67% | 97.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.71% | -67.82% | -54.65% | -54.98% | 0.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 114.56% | -87.88% | -109.12% | -126.74% | -145.43% |
| Cash from Financing | -72.88% | -71.24% | -61.51% | -62.91% | -19.47% |
| Foreign Exchange rate Adjustments | 77.11% | 103.59% | 141.56% | 94.97% | 93.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.62% | 108.24% | -40.65% | -212.69% | 19.33% |